Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Telomir Pharmaceuticals Inc (TELO)

25 + Investors. Track Smart Money conviction in TELO. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↓ -8
Streak
1Q ▼
Buyers last Q
38%

Smart Money Signals — TELO

Based on 25 hedge funds · latest filing: 2026 Q1 · updated quarterly

📉

Selling streak — 1 quarter in a row

last 6Q
For 1 consecutive quarter, more hedge funds reduced or closed their TELO positions than added to them. Sustained institutional selling is a meaningful warning sign — these are professionals with deep research teams collectively deciding to exit.
🔻

Below peak — only 60% of 2.2Y high

60% of all-time peak
Only 25 funds hold TELO today versus a peak of 42 funds at 2025 Q1 — just 60% of the maximum. Low institutional ownership can mean the stock is out of favor, but it also means there's a large pool of potential buyers if sentiment turns.
📉

Outflows — 40% fewer funds vs a year ago

fund count last 6Q
17 fewer hedge funds hold TELO compared to a year ago (-40% decline). When institutions consistently reduce their exposure, it's worth exploring the underlying fundamental reasons driving them away.
🔴

Heavy selling pressure — only 38% buying

9 buying15 selling
Last quarter: 15 funds sold vs only 9 buyers. This is widespread institutional distribution — not a few funds rebalancing, but a broad exit. High conviction bearish signal.
➡️

Steady new buyers — ~4 new funds per quarter

new funds entering per quarter
Funds opening this position for the first time: 16 → 6 → 9 → 4. A stable flow of new institutional buyers suggests ongoing interest without signs of either acceleration or slowdown.
🔄

Mostly new holders — 44% entered in last year

■ 8% conviction (2yr+) ■ 48% medium ■ 44% new
Only 2 funds (8%) have held >2 years. The majority of current holders are relatively new to the position. New holders tend to sell faster when prices drop — a shallow conviction base that could amplify any sell-off.
⚠️

Saturation — most institutions already know this story

9 → 16 → 6 → 9 → 4 new funds/Q
New funds entering each quarter: 16 → 6 → 9 → 4. Far fewer institutions are entering now vs. a year ago. When the pool of potential new buyers shrinks this fast, future price support from institutional inflows weakens significantly.
📊

Mixed cohorts — 0% veterans, 52% new entrants

■ 0% veterans ■ 48% 1-2yr ■ 52% new
Of 25 current holders: 0 (0%) held 2+ years, 12 held 1–2 years, 13 (52%) entered in the past year. Balanced distribution — some institutional memory, some recent momentum buyers.
✅

Strong quality — 25% AUM from major funds

25% from top-100 AUM funds
9 of 25 holders rank in the top 100 by AUM, accounting for 25% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.
2.7
out of 10
Low Exit Risk
Exit risk score 2.7/10 — low institutional crowding. Ownership is below peak levels, holder base is relatively sticky, and buying momentum is positive.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — TELO

In 2026 Q1, 9 hedge funds were net buyers of TELO (4 opened a new position, 5 added to an existing one), while 15 reduced or exited (3 trimmed, 12 sold completely) — a 38% buyer ratio, indicating net institutional distribution. 25% of total institutional value in TELO is held by top-100 AUM funds, reflecting strong institutional quality. Net fund flow last quarter: -8 funds (more exits than new entries). Total institutional holders: 25.

Hedge Fund Ownership: TELO

How many hedge funds hold TELO — quarterly history vs. share price
Quarterly hedge fund ownership of TELO vs. share price

Market Analysis: TELO

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: TELO

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy Telomir Pharmaceuticals Inc (TELO) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much TELO has moved relative to its sector benchmark (XLV) since the 2026 Q1 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End March 31, 2026 · 82d ago
TELO
+9.2%
XLV
+1.9%

TELO outperformed XLV by +7.3% since March 31, 2026.

Since 13F Filing Date May 15, 2026 · 37d ago
TELO
+12.7%
XLV
+3.0%

Since the filing became public, TELO outperformed XLV by +9.7% .

Interpretation: The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference. Learn more →

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

4 top-rated funds 0 high-conviction
Consensus
3.0
/ 10
breadth
×
Elite
0.0
/ 10
conviction
Hedge Fund Positioning: TELO
25 + Investors

Track Smart Money conviction in TELO. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q1) Prior (2025 Q4) Change
Funds Holding 25 33 -24.24%
13F Shares 2M 2M -2.28%
Total Value $3M $3M -4.47%
New Positions 4 9 -5
Increased Positions 5 3 +2
Closed Positions 12 7 +5
Reduced Positions 3 7 -4
Total Calls 0 0 -
Total Puts 0 0 -
PUT/CALL Ratio 0.0 0.0 Bullish

Statistics: TELO

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q1)

25 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in TELO. Verified SEC 13F-HR filings.

QUARTER:
Top 21 TELO holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Suncoast Equity Management 0.01% 51,194 $67K
2 Praetorian Wealth Management, Inc. 0.01% 20,000 $27K
3 Morton Capital Management LLC/CA 0.00% 12,658 $16K
4 XTX Topco Ltd 0.00% 36,061 $47K
5 World Investment Advisors 0.00% 37,037 $48K
6 OneDigital Investment Advisors LLC 0.00% 23,000 $30K
7 Vestmark Advisory Solutions, Inc. 0.00% 13,100 $17K
8 Kestra Private Wealth Services, LLC 0.00% 11,000 $14K
9 Clearstead Advisors, LLC 0.00% 12,530 $16K
10 Regions Financial Corp 0.00% 10,638 $14K
11 Millennium Management LLC 0.00% 129,060 $168K
12 Osaic Holdings, INC. 0.00% 35,795 $47K
13 Vanguard Fiduciary Trust Co 0.00% 135,541 $176K
14 Vanguard Capital Management LLC 0.00% 995,373 $1.3M
15 BlackRock, Inc. 0.00% 289,198 $376K
16 UBS Group AG 0.00% 9,213 $12K
17 Goldman Sachs Group Inc 0.00% 10,411 $14K
18 Caitong International Asset Management Co., Ltd 0.00% 2 —
19 Jones Financial Companies Lllp 0.00% 600 —
20 SBI Securities Co., Ltd. 0.00% 4 —
21 BNP Paribas Financial Markets 0.00% 206 —
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Telomir Pharmaceuticals Inc (TELO)

What does the Smart Money Trend signal show for TELO?

Selling streak — 1 quarter in a row: For 1 consecutive quarter, more hedge funds reduced or closed their TELO positions than added to them. Sustained institutional selling is a meaningful warning sign — these are professionals with deep research teams collectively deciding to exit.

What is the institutional breadth score for TELO?

Heavy selling pressure — only 38% buying: Last quarter: 15 funds sold vs only 9 buyers. This is widespread institutional distribution — not a few funds rebalancing, but a broad exit. High conviction bearish signal.

What is the fund quality score for TELO holders?

Strong quality — 25% AUM from major funds: 9 of 25 holders rank in the top 100 by AUM, accounting for 25% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.

How long have hedge funds held TELO?

Mostly new holders — 44% entered in last year: Only 2 funds (8%) have held >2 years. The majority of current holders are relatively new to the position. New holders tend to sell faster when prices drop — a shallow conviction base that could amplify any sell-off.

Is it too late to buy Telomir Pharmaceuticals Inc (TELO) following the 2026 Q1 hedge fund 13F filings?

As of today, TELO has moved +12.7% since the 2026 Q1 13F filing date (May 15, 2026), compared to +3.0% for the XLV sector ETF — an outperformance of +9.7%. Since the quarter end (March 31, 2026), TELO has gained +9.2% vs +1.9% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →